| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 12/23/2004 | WO2004110994A1 Novel piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams |
| 12/23/2004 | WO2004110986A1 Benzamide derivative or salt thereof |
| 12/23/2004 | WO2004110492A2 Composition comprising triptans and nsaids |
| 12/23/2004 | WO2004110489A1 MEDICINAL COMPOSITION FOR PREVENTING OR TREATING Th1 TYPE IMMUNOLOGICAL DISEASE |
| 12/23/2004 | WO2004110454A1 COMPOSITION FOR TREATMENT FOR OR PREVENTION OF DISEASE NECESSITATING ADMINISTRATION OF ADENOSINE A2a RECEPTOR AGONIST |
| 12/23/2004 | WO2004110451A1 Combinations for opioid-based treatment of pain comprising 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 12/23/2004 | WO2004110445A1 Phentanyl-containing adhesive patch for application to oral-cavity mucosa |
| 12/23/2004 | WO2004110444A1 Neurocyte protective agent |
| 12/23/2004 | WO2004110443A1 Treatment for alzheimer's disease and related conditions |
| 12/23/2004 | WO2004110440A1 Synergistic combinations including n-acylated 4-hydroxyphenylamine derivatives and caffeine |
| 12/23/2004 | WO2004110437A1 Asenapine for the treatment of schizophrenia in a patient with overweight or predisposition for overweight |
| 12/23/2004 | WO2004110433A1 Pyrrolidin-1, 2- dicarboxylic acid- 1- [(4- ethinyl- phenyl) - amid]- 2- [(phenyl)- amid] derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis |
| 12/23/2004 | WO2004110421A1 Use of 2-amino-1-3-propanediol derivatives for the manufacture of a medicament for the treatment of various types of pain |
| 12/23/2004 | WO2004110415A2 Substituted 1, 4-di-piperidin-4-yl-piperazine derivative combined with an opioid analgesic and their use for the treatment of pain and side-effects associated with opioid-based treatments |
| 12/23/2004 | WO2004110400A2 Implantable polymeric device for sustained release of nalmefene |
| 12/23/2004 | WO2004110379A2 A1 adenosine receptor antagonists |
| 12/23/2004 | WO2004110344A2 New azetidine compounds |
| 12/23/2004 | WO2004089908A3 3-azabicyclo[3.2.1]octane derivatives |
| 12/23/2004 | WO2004083215A9 Nitrogeneous polycyclic derivatives useful as chelators of metal ions and their applications |
| 12/23/2004 | WO2004083171A3 Use of pyridin-2-ylmethylamine derivatives for the treatment of chronic neuropathological or psychogenic pain symptoms |
| 12/23/2004 | WO2004062554A3 Enhancement of dopaminergic neuron generation and survital |
| 12/23/2004 | WO2004009062A3 NMDA RECEPTOR ANTAGONISTS AND THEIR USE IN INHIBITING ABNORMAL HYPERPHOSPHORYLATION OF MICROTUBULE ASSOCIATED PROTEIN tau |
| 12/23/2004 | WO2003082198A3 Methods of treatment with lxr modulators |
| 12/23/2004 | WO2003076569A3 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same |
| 12/23/2004 | WO2003037167A3 Pathway of rantes-mediated chemokine synthesis in astrocytes and methods of use therefor |
| 12/23/2004 | WO2002074240A3 Anti-amyloid antibody based diagnosis and treatment of a neurological disease or disorder |
| 12/23/2004 | US20040260096 Novel substituted 4-phenyl-4-{1h-imidazol-2-yl}-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 12/23/2004 | US20040260094 such as 8-amino-4-benzylamino-quinoline-3-carboxylic acid ethyl ester; for treatment of Alzheimer's disease, Huntington's disease, Parkinson's disease, AIDS, stroke, ischemia, traumatic brain injury, spinal cord injury or osteoarthritis |
| 12/23/2004 | US20040260088 Novel compounds |
| 12/23/2004 | US20040260076 Isolation, purification and synthesis of procyanidin B2 and uses thereof |
| 12/23/2004 | US20040259954 Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy |
| 12/23/2004 | US20040259953 Use of the (1S,2R) enantiomer of milnacipran for the preparation of a drug |
| 12/23/2004 | US20040259944 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| 12/23/2004 | US20040259940 Precipitation from mother liquors by adding bases or acid addition salts to solution of citalopram |
| 12/23/2004 | US20040259939 Dissolving and precipitation a solution of citalopram in acid with solvent, adding base to liberate free base. |
| 12/23/2004 | US20040259930 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 12/23/2004 | US20040259928 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment |
| 12/23/2004 | US20040259924 A metabolite of repinotan hydrochloride that have high affinity for binding to the serotonin receptors of the 5-HT1A type; treating stroke or skull-brain trauma; anxiolytic agents; antidepressants; sexual, sleep and food disorders |
| 12/23/2004 | US20040259917 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5 |
| 12/23/2004 | US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence |
| 12/23/2004 | US20040259909 using an agonist of alpha 7 nicotinic acetylcholine receptors rather than those of 5HT3 receptors; tropisetron; spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidine-2'-one; N-(1-azabicyclo[2.2.2]oct-3-yl)(3-phenylbenzamide); N-(nitrogen heterocycle)-carboxamides or thiocarboxamides |
| 12/23/2004 | US20040259897 transplant rejection, rheumatoid arthritis, osteoarthritis, diabetes, asthma, inflammatory bowel disease, and chronic obstructive pulmonary disease; inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes |
| 12/23/2004 | US20040259892 c-kit inhibitor; unable to promote death of IL-3 dependent cells cultured in presence of IL-3; N-phenyl-2-pyrimidine-amine derivatives; 4-(4-methylpiperazine-1-ylmethyl)-N-[4-methyl-3-(4-pyridine-3-yl)pyrimidine-2 ylamino)phenyl]-benzamide |
| 12/23/2004 | US20040259890 trans-3'-oxo-N-(trans-4-phenylcyclohexyl)-spiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-carboxamide e.g.; neuropeptide Y receptor antagonists for treatment of bulimia, obesity or diabetes for example |
| 12/23/2004 | US20040259888 Antiischemic agents; cardiovascular disorders; analgesics; neurodegenerative disease |
| 12/23/2004 | US20040259879 Antiarthritic agents; colon cancer, neurodegenerative agents |
| 12/23/2004 | US20040259875 Incontinence; overactive bladder; neuropathic pain; neuralgia; analgesics; stroke; antiarthritic agents; antiinflammatory agents |
| 12/23/2004 | US20040259871 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses |
| 12/23/2004 | US20040259865 Laxative; adenosine receptor antagonist |
| 12/23/2004 | US20040259863 Type 4 phosphodiesterase inhibitors and uses thereof |
| 12/23/2004 | US20040259859 Therapy for diseases caused by opioid receptors; irratible bowel disorders; drug abuse; antidepressants; anxiolytic agents; schizophrenia; eating disorders |
| 12/23/2004 | US20040259842 Anticoagulants ; antiischemic agents; autoimmune disease; antihistamines; antiallergens; antihistamines; brain disorders; kidney disease; pancreatitis; Alzheimer's disease |
| 12/23/2004 | US20040259821 In nonaqueous solvent; therapy for blood disorders; anticancer agents |
| 12/23/2004 | US20040259820 Kit for delivering decitabine in vivo |
| 12/23/2004 | US20040259818 Glucoronide adduct as gaba ligand |
| 12/23/2004 | US20040259809 Pharmaceutical compositions including an antihistamine and a stimulant and method of use thereof |
| 12/23/2004 | US20040259805 Stimulant of milk ejection; contraction; stability |
| 12/23/2004 | US20040259787 C1q and collectin receptor |
| 12/23/2004 | US20040259786 Method of transporting a chimeric hybrid molecule across the blood brain barrier |
| 12/23/2004 | US20040259779 Novel neurotrophic factors |
| 12/23/2004 | US20040259767 Antiproliferative agents; therapy for human progessive leukoencephalophy ; suppression of dna viruses; anticancer agents |
| 12/23/2004 | US20040259254 for use treating various neurodegenerative or brain disorders or injuries via cell transplantation; incubating the cell derived from a mononuclear cell fraction isolated from bone marrow fluid or umbilical blood in a basal culture medium at given temperature range |
| 12/23/2004 | US20040259159 Role of LDL receptor protein-1 (LRP-1) in Alzheimer's disease |
| 12/23/2004 | US20040259110 Gene PRV-1 and its use |
| 12/23/2004 | US20040258766 Use of N2O in the treatment of post-ischemic brain cell deterioration |
| 12/23/2004 | US20040258758 Stabilizer adsorped on particle surface; adhere to gut increasing time for absorption, and effectiveness; low dosage; antiepileptic, anxiolytic and antidepressant agents; post traumatic stress syndrome bipolar and psychological disorders; schizophrenia |
| 12/23/2004 | US20040258741 Percutaneous absorption preparations |
| 12/23/2004 | US20040258716 Spill-resistant, semi-solid, aqueous pharmaceutical suspension for oral administration comprising a water-insoluble medicine in a stabilizing vehicle of glycerin, sorbitol, propylene glycol and thickener, e.g. Carbopol"; palatable; homogeneous; shelf life of <36 months; crystal growth inhibitors |
| 12/23/2004 | US20040258689 Augmenting activin induced signaling in cells; screening for complex inhibitors; treatment of reproductive, developmental, skin, bone, hepatic, hematopoietic and/or central nervous system disorders; prostrate cancer |
| 12/23/2004 | US20040258678 Isolated nucleic acid having high identity to sequence 215; vectors, host cells, antibodies |
| 12/23/2004 | US20040258656 Identified via SELEX method; phosphate-containing ligand is conjugated to polyoxyethylene glycol; transforming growth factor (TGF); pharmacokinetics |
| 12/23/2004 | US20040258622 Nonozone depleting aerosol formulation employing hydrofluoroalkane propellants |
| 12/23/2004 | CA2531829A1 Synergistic combinations including n-acylated 4-hydroxyphenylamine derivatives and caffeine |
| 12/23/2004 | CA2528929A1 Cyclic tertiary amine compound |
| 12/23/2004 | CA2528905A1 Neurocyte protective agent |
| 12/23/2004 | CA2528883A1 Pharmaceutical compositions for preventing or treating th1-mediated immune diseases |
| 12/23/2004 | CA2528644A1 Novel piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams |
| 12/23/2004 | CA2528409A1 Use of 2-amino-1-3-propanediol derivatives for the manufacture of a medicament for the treatment of various types of pain |
| 12/23/2004 | CA2528395A1 Treatment for alzheimer's disease and related conditions |
| 12/23/2004 | CA2528367A1 A1 adenosine receptor antagonists |
| 12/23/2004 | CA2528365A1 Asenapine for the treatment of schizophrenia in a patient with overweight or predisposition for overweight |
| 12/23/2004 | CA2527906A1 Acylated imidazo[2,1-b]-1,3,4,-thiadiazole-2-sulfonamides and uses thereof |
| 12/23/2004 | CA2527903A1 Imidazo[2,1-b]-1,3,4-thiadiazole sulfoxides and sulfones |
| 12/23/2004 | CA2527856A1 Substituted 1, 4-di-piperidin-4-yl-piperazine derivative combined with an opioid analgesic and their use for the treatment of pain and side-effects associated with opioid-based treatments |
| 12/23/2004 | CA2527368A1 Pharmaceutical composition |
| 12/23/2004 | CA2527236A1 Thiotungstate analogues and uses thereof |
| 12/23/2004 | CA2527033A1 2-substitued 5,6-diaryl-pyrazine derivatives as cb1 modulators |
| 12/23/2004 | CA2526387A1 Benzamide derivative or salt thereof |
| 12/23/2004 | CA2526209A1 Cyclic hydroxylamine as psychoactive compounds |
| 12/23/2004 | CA2526101A1 Implantable polymeric device for sustained release of nalmefene |
| 12/23/2004 | CA2525917A1 Compositions and methods including a recombinant human mab that promotes cns remyelination |
| 12/23/2004 | CA2525782A1 Degradation of glycosaminoglycans in extracellular matrix to treat cns injury |
| 12/22/2004 | EP1489178A1 Polypeptides binding to human syntaxin 1a |
| 12/22/2004 | EP1489172A1 Nuclear receptor err gamma 3 |
| 12/22/2004 | EP1489171A1 Functional molecule and process for producing the same |
| 12/22/2004 | EP1489163A1 Method of inducing growth of nerve stem cells |
| 12/22/2004 | EP1489096A1 Novel hemepeptide |
| 12/22/2004 | EP1489083A1 Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 12/22/2004 | EP1489081A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient |
| 12/22/2004 | EP1489076A1 Cyclic hemiacetal derivative and use thereof |